French biotech company Ipsen to buy Kartos Therapeutics for $450 million - Reuters
French biotech company Ipsen to buy Kartos Therapeutics for $450 million Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxPZ2IxaFRzWXJfQ2hrMVVVY2puS2VZX3A4UXFJNWJmNjhTYVNKODB4RzZXNXV3RmdPRGtEbWlfcHptUk80d2kyNEJvQ1k3NkVub05fUmVZVkk5WmE4OXVUYjVSVG5RUmFyTkFPQkpILVVrTUtaX3p5aWpPRXdBNjN4bWQtUlpKMjViSm5Ld0Jwa2xlLTRQV0tXQllCN3RQYWExWW92UDZ6eklOeE9WV1E?oc=5" target="_blank">French biotech company Ipsen to buy Kartos Therapeutics for $450 million</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Warburg Pincus nears $7 billion deal for PANTHERx Rare, WSJ reports - Reuters
Warburg Pincus nears $7 billion deal for PANTHERx Rare, WSJ reports Reuters
July 10, 2026 at 05:35 PMAstraZeneca, Daiichi near UK pricing deal for breast cancer drug, Bloomberg News reports - Reuters
AstraZeneca, Daiichi near UK pricing deal for breast cancer drug, Bloomberg News reports Reuters
July 8, 2026 at 06:34 PMGSK's Jemperli meets main goal in mid-stage rectal cancer trial - Reuters
GSK's Jemperli meets main goal in mid-stage rectal cancer trial Reuters
July 13, 2026 at 06:45 PMBayer gets €3 billion in Apollo deal for contraceptives unit - Reuters
Bayer gets €3 billion in Apollo deal for contraceptives unit Reuters
July 10, 2026 at 06:33 AMResMed to sell software business MatrixCare for $490 million - Reuters
ResMed to sell software business MatrixCare for $490 million Reuters
July 7, 2026 at 10:39 PMGSK, Hansoh's targeted cancer drug hits main survival goal in China trial - Reuters
GSK, Hansoh's targeted cancer drug hits main survival goal in China trial Reuters
July 10, 2026 at 01:46 PM